They knew exactly what they were doing. Anyone who did any DD...

They knew exactly what they were doing. Anyone who did any DD would have known what direction a funded multiple phase 3 Co. with a $36M MC was headed. Even after the selloff last year, the absolute lowest price was 18c. Prior to the progress of REMAP-CAP, acceptance of Clarity 2, Follow up of DKD analysis, Innovation Passport and ILAP status, Accelerated FDA approval on FSGS and Study design approval, use with endothelin A inhibitors inc. patent applied.
There were several investor presentations released with "hope" of partnerships. If the rest of us lost interest they would have been raising at 10c

I put my money in on the first day. I'm happy we got funding and can now progress, but as it was put previously, it is dilution away from existing holders who should be rewarded, including any who came in on the several rehashed investor presentations. I know Insto's will get the lions share, and retail raising is harder, but a 83/17 split is a bit rude, especially when there was provisions to offload any shortfall back to the insto's anyway.